DGKA and hepatocellular carcinoma: DGKα is abundantly expressed in several cancer cell lines including hepatocellular carcinoma, melanoma, glioblastoma, colon adenocarcinoma, and breast adenocarcinoma cells, enhancing their progression and proliferation, and attenuating apoptosis [8,9,10,11].